Evidence map›Paper›PMID 34511042›Full record

ArticleBioengineered2021

Long non-coding RNA SOX21-AS1 modulates lung cancer progress upon microRNA miR-24-3p/PIM2 axis.

Fengfeng Wang, Tengfei Gu, Yao Chen, Yu Chen, Dan Xiong, Yehan Zhu

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Role of PIM2 in acute lung injury induced by sepsis.Experimental and therapeutic medicine · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Fengfeng WangDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.
Tengfei GuDepartment of Anesthesiology, People's Hospital of Lianshui County, Lianshui, Jiangsu, China.
Yao ChenDepartment of Respiration, People's Hospital of Jingjiang, Jingjiang, Jiangsu, China.
Yu ChenDepartment of Respiration, People's Hospital of Jingjiang, Jingjiang, Jiangsu, China.
Dan XiongDepartment of Respiration, People's Hospital of Jingjiang, Jingjiang, Jiangsu, China.
Yehan ZhuDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.
First People's Hospital of Jingzhou · CNSoochow University · CNJingning County People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is a lethal cancer that threatens human health. Several studies have demonstrated the role of long non-coding RNAs (lncRNAs) in lung cancer.

Indexed as

Lung NeoplasmsAnimalsCell Line, TumorDisease ProgressionHumansLungMiceMice, NudeMicroRNAsProtein Serine-Threonine KinasesProto-Oncogene ProteinsRNA, Long Noncodinglong noncoding RNA SOX21-AS1, humanMicroRNAsMIRN24 microRNA, humanPIM2 protein, humanProtein Serine-Threonine KinasesProto-Oncogene ProteinsRNA, Long NoncodingLung cancermiR-24-3pPIM2SOX21-AS1

Identifiers

PMID34511042
PMCPMC8806559
OpenAlexW3200160971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.